Chromatin Bioscience signs a Research Collaboration with Johnson & Johnson

In this project, we will leverage our proprietary chromatinLENS platform to drive advancements in synthetic promoter design and its applications in transformative healthcare solutions.

This collaboration underscores the growing recognition of our platform's potential to deliver precise, cell-type-selective, and durable gene expression, supporting innovative approaches in gene and cell therapies.

We are excited to embark on this journey with Johnson & Johnson and look forward to the opportunities this collaboration will bring.